Arctic Vision (Shanghai) Biotechnology Co.
Latest round
- Series B
Last raised
- Mar 2021
Total raised
- $132M
Investors
- 6
About Arctic Vision (Shanghai) Biotechnology Co.
, Ltd.Founded in 2019 and headquartered in Shanghai, China, Arctic Vision focuses on creating advanced treatments for various eye conditions. The CEO, Dr.Arctic Vision specializes in developing innovative ophthalmic therapies that address significant unmet clinical needs. The company’s core product offerings encompass a portfolio that spans from pre-clinical to commercial stages, focusing on advanced treatment options for various eye conditions, including glaucoma, retinal diseases, and dry eye syndromes.Arctic Vision's revenue generation model is centered around B2B transactions, supplying pharmaceutical products to healthcare institutions and specialty pharmacies. The company collaborates with distributors and healthcare providers to ensure product availability in clinics and hospitals, with structured pricing based on volume purchases or exclusive distribution rights in specific regions., Ltd. The company plans to introduce new products targeting various eye conditions and is focusing on expanding into new markets across Asia and potentially beyond by 2023. The strategic investments aim to enhance their operational capabilities and market reach.
Who invested in Arctic Vision (Shanghai) Biotechnology Co.
6 investors across 3 rounds
See all investors in Arctic Vision (Shanghai) Biotechnology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Arctic Vision (Shanghai) Biotechnology Co.
Who invested in Arctic Vision (Shanghai) Biotechnology Co.?
Arctic Vision (Shanghai) Biotechnology Co. has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Arctic Vision (Shanghai) Biotechnology Co. raised?
Arctic Vision (Shanghai) Biotechnology Co. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Arctic Vision (Shanghai) Biotechnology Co. last raise money?
Arctic Vision (Shanghai) Biotechnology Co.'s most recent round on record is a Series B, in Mar 2021.
What does Arctic Vision (Shanghai) Biotechnology Co. do?
Arctic Vision (Shanghai) Biotechnology Co. is a healthcare specialists company.
Where is Arctic Vision (Shanghai) Biotechnology Co. headquartered?
Arctic Vision (Shanghai) Biotechnology Co. is headquartered in Shanghai, China.
Which VCs invest in companies like Arctic Vision (Shanghai) Biotechnology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back healthcare specialists companies at Arctic Vision (Shanghai) Biotechnology Co.'s stage. Their profiles are linked below.
VCs backing healthcare specialists startups at Series B
Raising like Arctic Vision (Shanghai) Biotechnology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.